Christopher S Lee1, James O Mudd, Jill M Gelow, Thuan Nguyen, Shirin O Hiatt, Jennifer K Green, Quin E Denfeld, Julie T Bidwell, Kathleen L Grady. 1. Christopher S. Lee, PhD, RN, FAHA Associate Professor, Schools of Nursing and Medicine, Oregon Health & Science University, Portland. James O. Mudd, MD Assistant Professor, Director of Heart Failure/Transplant Cardiology, School of Medicine, Oregon Health & Science University, Portland. Jill M. Gelow, MD, MPH Assistant Professor, School of Medicine, Oregon Health & Science University, Portland. Thuan Nguyen, MD, PhD Assistant Professor, School of Medicine, Oregon Health & Science University, Portland. Shirin O. Hiatt, MPH, MS, RN Research Project Director, School of Nursing, Oregon Health & Science University, Portland. Jennifer K. Green, MS Research Associate, School of Nursing, Oregon Health & Science University, Portland. Quin E. Denfeld, BSN, RN, CCRN Research Associate, School of Nursing, Oregon Health & Science University, Portland. Julie T. Bidwell, BSN, RN Research Associate, School of Nursing, Oregon Health & Science University, Portland. Kathleen L. Grady, PhD, APN, FAHA, FAAN Associate Professor, Administrative Director, Center for Heart Failure, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Abstract
BACKGROUND: Unexplained heterogeneity in response to ventricular assist device (VAD) implantation for the management of advanced heart failure impedes our ability to predict favorable outcomes, provide adequate patient and family education, and personalize monitoring and symptom management strategies. The purpose of this article was to describe the background and the design of a study entitled "Profiling Biobehavioral Responses to Mechanical Support in Advanced Heart Failure" (PREMISE). STUDY DESIGN AND METHODS: PREMISE is a prospective cohort study designed to (1) identify common and distinct trajectories of change in physical and psychological symptom burden; (2) characterize common trajectories of change in serum biomarkers of myocardial stress, systemic inflammation, and endothelial dysfunction; and (3) quantify associations between symptoms and biomarkers of pathogenesis in adults undergoing VAD implantation. Latent growth mixture modeling, including parallel process and cross-classification modeling, will be used to address the study aims and will entail identifying trajectories, quantifying associations between trajectories and both clinical and quality-of-life outcomes, and identifying predictors of favorable symptom and biomarker responses to VAD implantation. CONCLUSIONS: Research findings from the PREMISE study will be used to enhance shared patient and provider decision making and to shape a much-needed new breed of interventions and clinical management strategies that are tailored to differential symptom and pathogenic responses to VAD implantation.
BACKGROUND: Unexplained heterogeneity in response to ventricular assist device (VAD) implantation for the management of advanced heart failure impedes our ability to predict favorable outcomes, provide adequate patient and family education, and personalize monitoring and symptom management strategies. The purpose of this article was to describe the background and the design of a study entitled "Profiling Biobehavioral Responses to Mechanical Support in Advanced Heart Failure" (PREMISE). STUDY DESIGN AND METHODS: PREMISE is a prospective cohort study designed to (1) identify common and distinct trajectories of change in physical and psychological symptom burden; (2) characterize common trajectories of change in serum biomarkers of myocardial stress, systemic inflammation, and endothelial dysfunction; and (3) quantify associations between symptoms and biomarkers of pathogenesis in adults undergoing VAD implantation. Latent growth mixture modeling, including parallel process and cross-classification modeling, will be used to address the study aims and will entail identifying trajectories, quantifying associations between trajectories and both clinical and quality-of-life outcomes, and identifying predictors of favorable symptom and biomarker responses to VAD implantation. CONCLUSIONS: Research findings from the PREMISE study will be used to enhance shared patient and provider decision making and to shape a much-needed new breed of interventions and clinical management strategies that are tailored to differential symptom and pathogenic responses to VAD implantation.
Authors: Josef Stehlik; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Jason D Christie; Anne I Dipchand; Fabienne Dobbels; Richard Kirk; Axel O Rahmel; Marshall I Hertz Journal: J Heart Lung Transplant Date: 2012-10 Impact factor: 10.247
Authors: M A Dew; R L Kormos; S Winowich; R C Harris; E A Stanford; L Carozza; B P Griffith Journal: J Heart Lung Transplant Date: 2001-11 Impact factor: 10.247
Authors: Jeremiah G Allen; Eric S Weiss; Justin M Schaffer; Nishant D Patel; Susan L Ullrich; Stuart D Russell; Ashish S Shah; John V Conte Journal: J Heart Lung Transplant Date: 2009-10-17 Impact factor: 10.247
Authors: Windy W Alonso; Kenneth M Faulkner; Bunny J Pozehl; Judith E Hupcey; Lisa A Kitko; Christopher S Lee Journal: Res Nurs Health Date: 2020-07-06 Impact factor: 2.228
Authors: Christopher S Lee; Jill M Gelow; Christopher V Chien; Shirin O Hiatt; Julie T Bidwell; Quin E Denfeld; Kathleen L Grady; James O Mudd Journal: J Cardiovasc Nurs Date: 2018 Mar/Apr Impact factor: 2.083
Authors: Christopher S Lee; Quin E Denfeld; Bradley E Aouizerat; Corrine Y Jurgens; Christopher V Chien; Emily Aarons; Jill M Gelow; Shirin O Hiatt; James O Mudd Journal: Heart Lung Date: 2018-10-09 Impact factor: 2.210
Authors: Quin E Denfeld; James O Mudd; Wohaib Hasan; Jill M Gelow; Shirin O Hiatt; Kerri Winters-Stone; Christopher S Lee Journal: Heart Lung Date: 2018-05-24 Impact factor: 2.210
Authors: Julie T Bidwell; Karen S Lyons; James O Mudd; Jill M Gelow; Christopher V Chien; Shirin O Hiatt; Kathleen L Grady; Christopher S Lee Journal: J Cardiovasc Nurs Date: 2017 Sep/Oct Impact factor: 2.083
Authors: Kenneth M Faulkner; Corrine Y Jurgens; Quin E Denfeld; Karen S Lyons; Jessica Harman Thompson; Christopher S Lee Journal: Heart Lung Date: 2020-05-18 Impact factor: 2.210
Authors: Quin E Denfeld; Christopher S Lee; William R Woodward; Shirin O Hiatt; James O Mudd; Beth A Habecker Journal: J Cardiovasc Nurs Date: 2019 Jul/Aug Impact factor: 2.083
Authors: Quin E Denfeld; Kenneth M Faulkner; Mary Roberts Davis; Beth A Habecker; Christopher V Chien; Jill M Gelow; James O Mudd; Shirin O Hiatt; Kathleen L Grady; Christopher S Lee Journal: Eur J Cardiovasc Nurs Date: 2021-10-27 Impact factor: 3.593